Insider Trading March 16, 2026

Gibraltar Industries CEO Buys $41,370 in Stock as Shares Trade Near Year Low

William T. Bosway adds 1,000 shares amid recent earnings miss and mixed market response

By Sofia Navarro ROCK
Gibraltar Industries CEO Buys $41,370 in Stock as Shares Trade Near Year Low
ROCK

Gibraltar Industries CEO William T. Bosway purchased 1,000 shares of common stock on March 13, 2026, at $41.37 per share, for a total of $41,370. The acquisition brings his direct holdings to 230,585 shares and comes as the stock trades close to its 52-week low. Recent quarterly results showed an EPS shortfall and revenue miss, though market reaction included some positive movement tied to strategic developments and backlog growth.

Key Points

  • Gibraltar Industries CEO William T. Bosway bought 1,000 shares on March 13, 2026, at $41.37 per share, for $41,370 total.
  • Following the purchase Bosway directly holds 230,585 shares and also has 43,981.51 RSUs (2018 MSPP Match) and 69,271.42 RSUs (2018 MSPP) in derivative holdings.
  • Gibraltar reported a Q4 2025 EPS of -0.08 versus an expected 1.02 and revenue of $268.7 million versus an expected $287.01 million; the stock is trading near a 52-week low and is down 31% over six months.

William T. Bosway, President and Chief Executive Officer of Gibraltar Industries, INC. (NASDAQ:ROCK), recorded a purchase of 1,000 shares of the company’s common stock at a price of $41.37 per share, for a total outlay of $41,370. The transaction was disclosed on a Form 4 filing with the Securities and Exchange Commission and was executed on March 13, 2026.

After the acquisition, Bosway directly owns 230,585 shares of Gibraltar Industries. The SEC filing also lists his derivative holdings, which include 43,981.51 Restricted Stock Units designated as 2018 MSPP Match and 69,271.42 Restricted Stock Units labeled 2018 MSPP.

The purchase occurred while Gibraltar’s share price was trading near its 52-week low of $37.79. The stock has fallen 31% over the past six months, according to the information in the filing.

Independent analysis noted in the filing indicates that InvestingPro considers Gibraltar Industries to appear undervalued at current market levels. The filing references the availability of a Pro Research Report covering ROCK and more than 1,400 other U.S. equities for investors seeking expanded research.

Separately, Gibraltar Industries reported results for the fourth quarter of 2025 that missed expectations. The company posted earnings per share of -0.08, below the forecast of 1.02. Revenue for the quarter came in at $268.7 million versus projected revenue of $287.01 million. Despite those headline misses, the market reaction included some positive movement in pre-market trading, with commentary in the filing attributing at least part of that response to the company’s strategic acquisitions and growth in backlog.

These developments - the insider purchase, the disclosure of Bosway’s derivative holdings, and the mixed financial results for Q4 2025 - are all documented in the SEC filing and the company’s reported quarterly figures. Investors monitoring Gibraltar Industries may weigh the insider transaction alongside the recent earnings and revenue shortfalls as they consider the company’s near-term outlook.

Risks

  • Quarterly earnings per share and revenue missed analyst expectations - a risk for investor sentiment in the industrials and building products sectors.
  • The stock is trading near its 52-week low and has declined 31% over six months, signaling potential market uncertainty for Gibraltar Industries and related construction and manufacturing suppliers.
  • Market response to the earnings miss was mixed; while some positive pre-market movement was noted, the underlying financial shortfalls present continued uncertainty for near-term performance.

More from Insider Trading

Marvell Technology President Sells $1.1M in Stock as Shares Trade Near Yearly High Apr 6, 2026 Edward Lampert Sells $58.5 Million in Lands’ End Stock; Company Posts Q4 Shortfall, Announces $100M Buyback Program Apr 6, 2026 NeonC/NeOnc President Buys $153,398 in Stock as Company Advances Financing and Clinical Timeline Apr 6, 2026 Edwards Lifesciences Executive Executes Option Exercise, Sells 1,019 Shares Apr 6, 2026 Penumbra Director Executes $32,822 Stock Sale Amid Deal and Upbeat Quarterly Results Apr 6, 2026